articleAAPS PharmSciTechMar 18, 2026HYBRID OA

Engineered Novel Brijaluronic Terpesomes for Brain-Targeted Quercetin Delivery: Optimization, Ex Vivo and Radiokinetics

SASadek AhmedKMKhaled M. AttallahMEMarwa Eid Sayyed

Cairo University · Egyptian Atomic Energy Authority

PubMed
Indexed incrossrefpubmed

Abstract

Abstract This research focuses on creating a novel Brijaluronic-based terpesomal system capable of transporting quercetin (QER) efficiently to the brain. The vesicles were fabricated through an ethanol-injection method and then refined using a structured optimization approach in Design-Expert® software. The influence of three main formulation parameters: terpene-to-drug ratio, surfactant type, and hyaluronic acid amount were evaluated. The optimization process was designed to maximize EE%, minimize VS, and maintain ZP within an acceptable stability range. The optimal formula hit a desirability target of 0.957. It achieved an 88.66% EE%, featured nano-carriers sized at 72.09 nm, and had a stable charge of −…

Citation impact

9
total citations
FWCI
94.07
Percentile
100%
References
108
Too recent for citation history.

Authors

3

Topics & keywords

Keywords
  • Quercetin
  • Ex vivo
  • Pulmonary surfactant
  • Hyaluronic acid
  • In vivo
  • Antioxidant
No related works found for this paper.

Funding